🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Ovarian Tissue Cryopreservation will be provided to cancer patients to allo...
Status
Recruiting
Location
Prince of Wales Hospital
Start Date
2023-08-01
Trial ID
NCT05830929
Treatments Being Tested
Poly(ADP-ribose) polymerase (PARP) inhibitors are anti-cancer treatments th...
Status
Recruiting
Location
Centre Hospitalier Universitaire d'Amiens Picardie Site Sud
Start Date
2024-09-24
Trial ID
NCT06572735
Treatments Being Tested
This study investigates the impact of perioperative inhibition of beta-adre...
Status
Recruiting
Location
The Chaim Sheba Medical Center
Start Date
2025-03-12
Trial ID
NCT06839144
The purpose of this study is to determine whether or not there are more com...
Status
Completed
Location
Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona
Start Date
2014-07
Trial ID
NCT02676726
RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormon...
Status
Completed
Location
Cancer Research Campaign Trials Unit-Birmingham (CRCTU)
Start Date
1993-06
Trial ID
NCT00002582
The aim of this study is to assess the prevalence of distress, anxiety and ...
Status
Completed
Location
Universitair Ziekenhuis UZBrussel
Start Date
2020-09-01
Trial ID
NCT04253327
Treatments Being Tested
The purpose of this phase 2 study is to assess the feasibility and efficacy...
Status
Terminated
Location
Duke University Medical Center
Start Date
2020-11-04
Trial ID
NCT04434560
Treatments Being Tested
PREMIERE parallel, non-comparative, two-arm, randomized 1:1, open-label, mu...
Status
Recruiting
Location
ICO Badalona
Start Date
2023-02-03
Trial ID
NCT05982093
Treatments Being Tested
RATIONALE: Giving chemotherapy before a peripheral stem cell transplant sto...
Status
Completed
Location
Multiple Locations
Start Date
2001-01
Trial ID
NCT00550784
Imatinib mesylate may stop the growth of tumor cells by blocking the enzyme...
Status
Terminated
Location
Cancer and Leukemia Group B
Start Date
2002-06
Trial ID
NCT00042952
Treatments Being Tested